• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
High frequency of the PNPLA3 rs738409 [G] single-nucleotide polymorphism in Hmong individuals as a potential basis for a predisposition to chronic liver disease.肝磷脂酶 A2 基因(PNPLA3)rs738409 [G] 单核苷酸多态性在苗人个体中高频出现,可能是慢性肝病易感性的基础。
Cancer. 2018 Apr 1;124 Suppl 7(Suppl 7):1583-1589. doi: 10.1002/cncr.31122.
2
Association of single nucleotide polymorphism at PNPLA3 with fatty liver, steatohepatitis, and cirrhosis of liver.PNPLA3基因单核苷酸多态性与脂肪肝、脂肪性肝炎及肝硬化的关联
Indian J Gastroenterol. 2017 Sep;36(5):366-372. doi: 10.1007/s12664-017-0784-y. Epub 2017 Oct 4.
3
Linked PNPLA3 polymorphisms confer susceptibility to nonalcoholic steatohepatitis and decreased viral load in chronic hepatitis B.连锁的PNPLA3基因多态性赋予非酒精性脂肪性肝炎易感性,并降低慢性乙型肝炎的病毒载量。
World J Gastroenterol. 2015 Jul 28;21(28):8605-14. doi: 10.3748/wjg.v21.i28.8605.
4
Association Between PNPLA3 rs738409 C>G Variant and Liver-Related Outcomes in Patients With Nonalcoholic Fatty Liver Disease.载脂蛋白 L3 基因 rs738409C>G 变异与非酒精性脂肪性肝病患者肝脏相关结局的关系。
Clin Gastroenterol Hepatol. 2020 Apr;18(4):935-944.e3. doi: 10.1016/j.cgh.2019.08.011. Epub 2019 Aug 13.
5
Role of the PNPLA3 I148M polymorphism in nonalcoholic fatty liver disease and fibrosis in Korea.PNPLA3 I148M基因多态性在韩国非酒精性脂肪性肝病和肝纤维化中的作用
Dig Dis Sci. 2014 Dec;59(12):2967-74. doi: 10.1007/s10620-014-3279-z. Epub 2014 Jul 29.
6
Validation of PNPLA3 polymorphisms as risk factor for NAFLD and liver fibrosis in an admixed population.验证 PNPLA3 多态性作为混合人群非酒精性脂肪性肝病和肝纤维化的危险因素。
Ann Hepatol. 2019 May-Jun;18(3):466-471. doi: 10.1016/j.aohep.2018.10.004. Epub 2019 Apr 18.
7
Association of PNPLA3 rs738409 G/C gene polymorphism with nonalcoholic fatty liver disease in children: a meta-analysis.载脂蛋白基因多态性与儿童非酒精性脂肪性肝病的关系: 荟萃分析。
BMC Med Genet. 2020 Aug 18;21(1):163. doi: 10.1186/s12881-020-01098-8.
8
Association of the rs738409 polymorphism in PNPLA3 with liver damage and the development of nonalcoholic fatty liver disease.载脂蛋白基因 3 上 rs738409 多态性与肝损伤及非酒精性脂肪性肝病的发生相关。
BMC Med Genet. 2010 Dec 22;11:172. doi: 10.1186/1471-2350-11-172.
9
Carriage of the PNPLA3 rs738409 C >G polymorphism confers an increased risk of non-alcoholic fatty liver disease associated hepatocellular carcinoma.载脂蛋白基因 PNPLA3 rs738409C>G 多态性增加非酒精性脂肪性肝病相关肝细胞癌的风险。
J Hepatol. 2014 Jul;61(1):75-81. doi: 10.1016/j.jhep.2014.02.030. Epub 2014 Mar 6.
10
No correlation between PNPLA3 rs738409 genotype and fatty liver and hepatic cirrhosis in Japanese patients with HCV.在日本丙型肝炎患者中,PNPLA3 rs738409 基因型与脂肪肝和肝硬化之间无相关性。
PLoS One. 2013 Dec 11;8(12):e81312. doi: 10.1371/journal.pone.0081312. eCollection 2013.

引用本文的文献

1
Disparities in Metabolic Dysfunction-Associated Steatotic Liver Disease Prevalence, Diagnosis, Treatment, and Outcomes: A Narrative Review.代谢功能障碍相关脂肪性肝病在患病率、诊断、治疗及预后方面的差异:一项叙述性综述
Dig Dis Sci. 2025 Jan;70(1):154-167. doi: 10.1007/s10620-024-08722-0. Epub 2024 Nov 19.
2
Metformin: Beyond Type 2 Diabetes Mellitus.二甲双胍:超越2型糖尿病
Cureus. 2024 Oct 17;16(10):e71730. doi: 10.7759/cureus.71730. eCollection 2024 Oct.
3
Molecular Genealogy of Metabolic-associated Hepatocellular Carcinoma.代谢相关型肝细胞癌的分子遗传学
Semin Liver Dis. 2024 May;44(2):147-158. doi: 10.1055/a-2289-2298. Epub 2024 Mar 18.
4
Non-alcoholic fatty liver disease (NAFLD) in Filipino North American patients: Results from a multi-ethnic cohort.菲律宾裔北美患者的非酒精性脂肪性肝病(NAFLD):多民族队列研究结果
Can Liver J. 2022 Feb 4;5(1):4-13. doi: 10.3138/canlivj-2021-0025. eCollection 2022 Winter.
5
An Unusual Case of Blastomycosis and Severe Lung Necrosis in a Hmong Woman With Preexisting Liver Cirrhosis.一名患有肝硬化的苗族女性发生芽生菌病及严重肺坏死的罕见病例。
Cureus. 2021 Aug 24;13(8):e17406. doi: 10.7759/cureus.17406. eCollection 2021 Aug.
6
Racial differences in prevalence and severity of non-alcoholic fatty liver disease.非酒精性脂肪性肝病患病率及严重程度的种族差异。
World J Hepatol. 2021 Jul 27;13(7):763-773. doi: 10.4254/wjh.v13.i7.763.
7
Interaction Between Alcohol Consumption and PNPLA3 Variant in the Prevalence of Hepatic Steatosis in the US Population.酒精摄入与 PNPLA3 变异在美人群中肝脂肪变性患病率的相互作用。
Clin Gastroenterol Hepatol. 2021 Dec;19(12):2606-2614.e4. doi: 10.1016/j.cgh.2020.08.054. Epub 2020 Aug 31.
8
Causal relationships between NAFLD, T2D and obesity have implications for disease subphenotyping.非酒精性脂肪性肝病、2 型糖尿病和肥胖之间的因果关系对疾病亚表型有影响。
J Hepatol. 2020 Aug;73(2):263-276. doi: 10.1016/j.jhep.2020.03.006. Epub 2020 Mar 10.
9
Healthcare Disparities Identified Between Hmong and Other Asian Origin Groups Living with Chronic Hepatitis B Infection in Sacramento County 2014-2017.2014-2017 年加利福尼亚州萨克拉门托县慢性乙型肝炎感染的苗族和其他亚裔原籍群体之间存在的医疗保健差异。
J Community Health. 2020 Apr;45(2):412-418. doi: 10.1007/s10900-019-00763-1.
10
Time, trust, and transparency: Lessons learned from collecting blood biospecimens for cancer research from the Asian American community.时间、信任和透明度:从亚裔美国人社区收集癌症研究用血液生物样本中获得的经验教训。
Cancer. 2018 Apr 1;124 Suppl 7(Suppl 7):1614-1621. doi: 10.1002/cncr.31168.

本文引用的文献

1
Adiposity amplifies the genetic risk of fatty liver disease conferred by multiple loci.肥胖会放大多个基因位点赋予的脂肪肝疾病遗传风险。
Nat Genet. 2017 Jun;49(6):842-847. doi: 10.1038/ng.3855. Epub 2017 Apr 24.
2
Prevalence of non-alcoholic fatty liver disease and risk factors for advanced fibrosis and mortality in the United States.美国非酒精性脂肪性肝病的患病率以及晚期肝纤维化和死亡的危险因素
PLoS One. 2017 Mar 27;12(3):e0173499. doi: 10.1371/journal.pone.0173499. eCollection 2017.
3
Cancer Statistics, 2017.《2017 年癌症统计》
CA Cancer J Clin. 2017 Jan;67(1):7-30. doi: 10.3322/caac.21387. Epub 2017 Jan 5.
4
Racial/ethnic disparities in hepatocellular carcinoma treatment and survival in California, 1988-2012.1988 - 2012年加利福尼亚州肝细胞癌治疗与生存方面的种族/族裔差异
World J Gastroenterol. 2016 Oct 14;22(38):8584-8595. doi: 10.3748/wjg.v22.i38.8584.
5
Concurrent fatty liver increases risk of hepatocellular carcinoma among patients with chronic hepatitis B.合并脂肪肝会增加慢性乙型肝炎患者患肝细胞癌的风险。
J Gastroenterol Hepatol. 2017 Mar;32(3):667-676. doi: 10.1111/jgh.13536.
6
Diabetes Prevalence and Risk Factors in Four Asian American Communities.四个亚裔美国人群体中的糖尿病患病率及风险因素
J Community Health. 2016 Dec;41(6):1264-1273. doi: 10.1007/s10900-016-0214-6.
7
Increasing Hepatitis B Testing and Linkage to Care of Foreign-Born Asians, Sacramento, California, 2012-2013.2012 - 2013年加利福尼亚州萨克拉门托市增加外国出生的亚洲人的乙肝检测及护理衔接情况
Public Health Rep. 2016 May-Jun;131 Suppl 2(Suppl 2):119-24. doi: 10.1177/00333549161310S218.
8
The MBOAT7-TMC4 Variant rs641738 Increases Risk of Nonalcoholic Fatty Liver Disease in Individuals of European Descent.MBOAT7-TMC4基因变异rs641738增加欧洲裔个体患非酒精性脂肪性肝病的风险。
Gastroenterology. 2016 May;150(5):1219-1230.e6. doi: 10.1053/j.gastro.2016.01.032. Epub 2016 Feb 2.
9
A global reference for human genetic variation.人类遗传变异的全球参考。
Nature. 2015 Oct 1;526(7571):68-74. doi: 10.1038/nature15393.
10
Nonalcoholic fatty liver disease: a systematic review.非酒精性脂肪性肝病:系统评价。
JAMA. 2015 Jun 9;313(22):2263-73. doi: 10.1001/jama.2015.5370.

肝磷脂酶 A2 基因(PNPLA3)rs738409 [G] 单核苷酸多态性在苗人个体中高频出现,可能是慢性肝病易感性的基础。

High frequency of the PNPLA3 rs738409 [G] single-nucleotide polymorphism in Hmong individuals as a potential basis for a predisposition to chronic liver disease.

机构信息

Department of Biochemistry and Molecular Medicine, University of California Davis, Sacramento, California.

Division of Hematology and Oncology, Department of Internal Medicine, University of California Davis, Sacramento, California.

出版信息

Cancer. 2018 Apr 1;124 Suppl 7(Suppl 7):1583-1589. doi: 10.1002/cncr.31122.

DOI:10.1002/cncr.31122
PMID:29578593
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5875707/
Abstract

BACKGROUND

An exploratory study was performed to determine the prevalence of the patatin-like phospholipase domain-containing protein 3 (PNPLA3) rs78409 [G] allele among the Hmong as a risk factor for nonalcoholic fatty liver disease (NAFLD). NAFLD/nonalcoholic steatohepatitis is the world's most common chronic liver disease and is expected to replace viral hepatitis as the leading cause of cirrhosis and potential precursor to hepatocellular carcinoma (HCC). Of all populations in California, the Hmong experience the highest risk of death from HCC and the highest prevalence of metabolic syndrome risk factors among Asians that predispose them to NAFLD. Here a genetic explanation was sought for the high rates of chronic liver disease among the Hmong. The literature pointed to the PNPLA3 rs738409 [G] allele as a potential genetic culprit.

METHODS

Cell-free DNA was isolated from 26 serum samples previously collected in community settings. Quantitative polymerase chain reaction-based single-nucleotide polymorphism (SNP) genotyping was performed with a validated TaqMan SNP genotyping assay, and results were analyzed with TaqMan Genotyper software.

RESULTS

The PNPLA3 rs738409 [C>G] variant occurred at a frequency of 0.46 (12 of 26; 95% confidence interval, 0.27-0.67). This carrier rate would rank the Hmong as the third highest population in the 1000 Genomes Project.

CONCLUSIONS

Although this small sample size limits the generalizability, the high frequency rates of this allele along with the presence of metabolic syndrome risk factors warrant further studies into the etiology of NAFLD among the Hmong. Cancer 2018;124:1583-9. © 2018 American Cancer Society.

摘要

背景

本探索性研究旨在确定 Hmong 人群中 patatin 样磷脂酶结构域蛋白 3(PNPLA3)rs78409[G]等位基因的流行率,该等位基因为非酒精性脂肪性肝病(NAFLD)的风险因素。NAFLD/非酒精性脂肪性肝炎是世界上最常见的慢性肝病,预计将取代病毒性肝炎成为肝硬化的主要原因,并可能成为肝细胞癌(HCC)的潜在前体。在加利福尼亚州的所有人群中,Hmong 人群患 HCC 死亡的风险最高,且亚洲人中患代谢综合征风险因素的比例最高,使他们易患 NAFLD。本研究旨在为 Hmong 人群中慢性肝病的高发病率提供遗传解释。文献指出,PNPLA3 rs738409[G]等位基因为潜在的遗传罪魁祸首。

方法

从社区环境中先前收集的 26 份血清样本中分离无细胞 DNA。采用经过验证的 TaqMan SNP 基因分型检测试剂盒进行基于定量聚合酶链反应的单核苷酸多态性(SNP)基因分型,并使用 TaqMan Genotyper 软件进行结果分析。

结果

PNPLA3 rs738409[C>G]变体的发生频率为 0.46(26 例中有 12 例;95%置信区间,0.27-0.67)。这一携带率将 Hmong 人群列为 1000 基因组计划中第三高的人群。

结论

尽管本研究的样本量较小限制了其普遍性,但该等位基因的高频率以及代谢综合征风险因素的存在,使得有必要进一步研究 Hmong 人群中 NAFLD 的病因。癌症 2018;124:1583-9. ©2018 美国癌症协会。